These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25463025)

  • 1. Cannabinoid modulation of drug reward and the implications of marijuana legalization.
    Covey DP; Wenzel JM; Cheer JF
    Brain Res; 2015 Dec; 1628(Pt A):233-43. PubMed ID: 25463025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens.
    Robbe D; Alonso G; Manzoni OJ
    Ann N Y Acad Sci; 2003 Nov; 1003():212-25. PubMed ID: 14684448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.
    Spanagel R
    Dialogues Clin Neurosci; 2020 Sep; 22(3):241-250. PubMed ID: 33162767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction.
    Peters KZ; Oleson EB; Cheer JF
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 31964646
    [No Abstract]   [Full Text] [Related]  

  • 5. A brain on cannabinoids: the role of dopamine release in reward seeking.
    Oleson EB; Cheer JF
    Cold Spring Harb Perspect Med; 2012 Aug; 2(8):. PubMed ID: 22908200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes.
    Wang H; Lupica CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():24-7. PubMed ID: 24495779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marijuana and cannabinoid regulation of brain reward circuits.
    Lupica CR; Riegel AC; Hoffman AF
    Br J Pharmacol; 2004 Sep; 143(2):227-34. PubMed ID: 15313883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction.
    Lupica CR; Riegel AC
    Neuropharmacology; 2005 Jun; 48(8):1105-16. PubMed ID: 15878779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.
    Mateo Y; Johnson KA; Covey DP; Atwood BK; Wang HL; Zhang S; Gildish I; Cachope R; Bellocchio L; Guzmán M; Morales M; Cheer JF; Lovinger DM
    Neuron; 2017 Dec; 96(5):1112-1126.e5. PubMed ID: 29216450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling.
    Wenzel JM; Cheer JF
    Neuropsychopharmacology; 2018 Jan; 43(1):103-115. PubMed ID: 28653666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.
    van der Stelt M; Di Marzo V
    Eur J Pharmacol; 2003 Nov; 480(1-3):133-50. PubMed ID: 14623357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CB1 receptors in psychostimulant addiction.
    Wiskerke J; Pattij T; Schoffelmeer AN; De Vries TJ
    Addict Biol; 2008 Jun; 13(2):225-38. PubMed ID: 18482432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.
    Zlebnik NE; Cheer JF
    J Neurosci; 2016 Oct; 36(40):10230-10238. PubMed ID: 27707960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid signaling system and brain reward: emphasis on dopamine.
    Gardner EL
    Pharmacol Biochem Behav; 2005 Jun; 81(2):263-84. PubMed ID: 15936806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.
    Spano MS; Fadda P; Fratta W; Fattore L
    Curr Drug Targets; 2010 Apr; 11(4):450-61. PubMed ID: 20017729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid.
    Burattini C; Battistini G; Tamagnini F; Aicardi G
    J Neurophysiol; 2014 Mar; 111(5):1046-55. PubMed ID: 24335217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of cannabinoids on brain neurotransmission.
    Cohen K; Weizman A; Weinstein A
    Eur J Neurosci; 2019 Aug; 50(3):2322-2345. PubMed ID: 30882962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance.
    Everett TJ; Gomez DM; Hamilton LR; Oleson EB
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110031. PubMed ID: 32663486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of endogenous cannabinoids in cerebral reward mechanisms].
    Wenger T; Fürst S
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):26-9. PubMed ID: 15125311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of basal ganglia and orbitofrontal cortex in goal-directed behavior.
    Hollerman JR; Tremblay L; Schultz W
    Prog Brain Res; 2000; 126():193-215. PubMed ID: 11105648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.